<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32699404</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>22</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>12184</StartPage><MedlinePgn>12184</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12184</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-68848-9</ELocationID><Abstract><AbstractText>We employed Mendelian randomization (MR) to evaluate the causal relationship between leukocyte telomere length (LTL) and amyotrophic lateral sclerosis (ALS) with summary statistics from genome-wide association studies (n&#x2009;=&#x2009;~&#x2009;38,000 for LTL and ~&#x2009;81,000 for ALS in the European population; n&#x2009;=&#x2009;~&#x2009;23,000 for LTL and ~&#x2009;4,100 for ALS in the Asian population). We further evaluated mediation roles of lipids in the pathway from LTL to ALS. The odds ratio per standard deviation decrease of LTL on ALS was 1.10 (95% CI 0.93-1.31, p&#x2009;=&#x2009;0.274) in the European population and 0.75 (95% CI 0.53-1.07, p&#x2009;=&#x2009;0.116) in the Asian population. This null association was also detected between LTL and frontotemporal dementia in the European population. However, we found that an indirect effect of LTL on ALS might be mediated by low density lipoprotein (LDL) or total cholesterol (TC) in the European population. These results were robust against extensive sensitivity analyses. Overall, our MR study did not support the direct causal association between LTL and the ALS risk in neither population, but provided suggestive evidence for the mediation role of LDL or TC on the influence of LTL and ALS in the European population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gao</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xinghao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International FTD-Genomics Consortium (IFGC)</CollectiveName></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Huashuo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China. hszhao@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Statistics and Data Analysis, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China. hszhao@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China. zpstat@xzhmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Statistics and Data Analysis, School of Public Health, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, People's Republic of China. zpstat@xzhmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/L501542/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G-0907</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U123160651</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0701075</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00024/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0900652</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AG062422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G0301152</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0400074</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 MH120794</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062268</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/N026004/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0901254</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AG066462</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>G0502157</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008077">Lipoproteins, LDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.49</RegistryNumber><NameOfSubstance UI="C509186">TERT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.49</RegistryNumber><NameOfSubstance UI="D019098">Telomerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008077" MajorTopicYN="N">Lipoproteins, LDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="Y">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019098" MajorTopicYN="N">Telomerase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059506" MajorTopicYN="N">Telomere Shortening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Dena G</ForeName><Initials>DG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nalls</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rohrer</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramasamy</LastName><ForeName>Adaikalavan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwok</LastName><ForeName>John B J</ForeName><Initials>JBJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dobson-Stone</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>William S</ForeName><Initials>WS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piguet</LastName><ForeName>Olivier</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartley</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haan</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hern&#xe1;ndez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Agust&#xed;n</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boada</LastName><ForeName>Merc&#xe8;</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borroni</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padovani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benussi</LastName><ForeName>Luisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Binetti</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ghidoni</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forloni</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albani</LastName><ForeName>Diego</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galimberti</LastName><ForeName>Daniela</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fenoglio</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serpente</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scarpini</LastName><ForeName>Elio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarim&#xf3;n</LastName><ForeName>Jordi</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lle&#xf3;</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blesa</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wald&#xf6;</LastName><ForeName>Maria Landqvist</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Christer</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>Ian R A</ForeName><Initials>IRA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hsiung</LastName><ForeName>Ging-Yuek R</ForeName><Initials>GR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mann</LastName><ForeName>David M A</ForeName><Initials>DMA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grafman</LastName><ForeName>Jordan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Attems</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKeith</LastName><ForeName>Ian G</ForeName><Initials>IG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Alan J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pietrini</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Huey</LastName><ForeName>Edward D</ForeName><Initials>ED</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wassermann</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baborie</LastName><ForeName>Atik</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaros</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tierney</LastName><ForeName>Michael C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pastor</LastName><ForeName>Pau</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Razquin</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ortega-Cubero</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alonso</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perneczky</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diehl-Schmid</LastName><ForeName>Janine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alexopoulos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurz</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rainero</LastName><ForeName>Innocenzo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rubino</LastName><ForeName>Elisa</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinessi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogaeva</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>George-Hyslop</LastName><ForeName>Peter St</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossi</LastName><ForeName>Giacomina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tagliavini</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giaccone</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rowe</LastName><ForeName>James B</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlachetzki</LastName><ForeName>Johannes C M</ForeName><Initials>JCM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uphill</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Collinge</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mead</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danek</LastName><ForeName>Adrian</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Deerlin</LastName><ForeName>Vivianna M</ForeName><Initials>VM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grossman</LastName><ForeName>Murray</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trojanowski</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van der Zee</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cruts</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Broeckhoven</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappa</LastName><ForeName>Stefano F</ForeName><Initials>SF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leber</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hannequin</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Golfier</LastName><ForeName>V&#xe9;ronique</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vercelletto</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brice</LastName><ForeName>Alexis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nacmias</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorbi</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bagnoli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piaceri</LastName><ForeName>Irene</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nielsen</LastName><ForeName>J&#xf8;rgen E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hjermind</LastName><ForeName>Lena E</ForeName><Initials>LE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riemenschneider</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mayhaus</LastName><ForeName>Manuel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ibach</LastName><ForeName>Bernd</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gasparoni</LastName><ForeName>Gilles</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pichler</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gu</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossor</LastName><ForeName>Martin N</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Nick C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warren</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spillantini</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Huw R</ForeName><Initials>HR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rizzu</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heutink</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snowden</LastName><ForeName>Julie S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rollinson</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Richardson</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruni</LastName><ForeName>Amalia C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maletta</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frangipane</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cupidi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernardi</LastName><ForeName>Livia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anfossi</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallo</LastName><ForeName>Maura</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conidi</LastName><ForeName>Maria Elena</ForeName><Initials>ME</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smirne</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rademakers</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Matt</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dennis W</ForeName><Initials>DW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graff-Radford</LastName><ForeName>Neill R</ForeName><Initials>NR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petersen</LastName><ForeName>Ronald C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knopman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Josephs</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boeve</LastName><ForeName>Bradley F</ForeName><Initials>BF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parisi</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seeley</LastName><ForeName>William W</ForeName><Initials>WW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karydas</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosen</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Swieten</LastName><ForeName>John C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dopper</LastName><ForeName>Elise G P</ForeName><Initials>EGP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seelaar</LastName><ForeName>Harro</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pijnenburg</LastName><ForeName>Yolande A L</ForeName><Initials>YAL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scheltens</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Logroscino</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capozzo</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Novelli</LastName><ForeName>Valeria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puca</LastName><ForeName>Annibale A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franceschi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Postiglione</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Milan</LastName><ForeName>Graziella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorrentino</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kristiansen</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiang</LastName><ForeName>Huei-Hsin</ForeName><Initials>HH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graff</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasquier</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rollin</LastName><ForeName>Adeline</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deramecourt</LastName><ForeName>Vincent</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lebouvier</LastName><ForeName>Thibaud</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kapogiannis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrucci</LastName><ForeName>Luigi</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pickering-Brown</LastName><ForeName>Stuart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singleton</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Momeni</LastName><ForeName>Parastoo</ForeName><Initials>P</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32699404</ArticleId><ArticleId IdType="pmc">PMC7376149</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-68848-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-68848-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9:617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Smoking is a cause of amyotrophic lateral sclerosis. High low-density lipoprotein cholesterol levels? Unsure. Ann. Neurol. 2019;85:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pubmed">30875450</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Fang F. Smoking and amyotrophic lateral sclerosis: a mendelian randomization study. Ann. Neurol. 2019;85:482&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">30786056</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, et al. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong CM, Lee XW, Wang X. Telomere shortening in human diseases. FEBS J. 2013;280:3180&#x2013;3193.</Citation><ArticleIdList><ArticleId IdType="pubmed">23647631</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat. Rev. Genet. 2019;20:299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">30760854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Belcher M, van der Harst P. Healthy aging and disease: role for telomere biology? Clin. Sci. (Lond.) 2011;120:427&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035527</ArticleId><ArticleId IdType="pubmed">21271986</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, et al. Association between telomere length and risk of cancer and non-neoplastic diseases a Mendelian randomization study. Jama Oncol. 2017;3:636&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638008</ArticleId><ArticleId IdType="pubmed">28241208</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum. Mol. Genet. 2015;24:5356&#x2013;5366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550826</ArticleId><ArticleId IdType="pubmed">26138067</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, et al. Exploring the causal pathway from telomere length to coronary heart disease: a network Mendelian randomization study. Circ. Res. 2017;121:214&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">28515044</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Ruiz C, et al. Senescence and inflammatory markers for predicting clinical progression in Parkinson's disease: the ICICLE-PD study. J. Parkinsons Dis. 2020;10:193&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029330</ArticleId><ArticleId IdType="pubmed">31868677</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, et al. Telomerase expression in amyotrophic lateral sclerosis (ALS) patients. J. Hum. Genet. 2014;59:555&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">25142509</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khleifat A, et al. Telomere length is greater in ALS than in controls: a whole genome sequencing study. Amyotroph. Lateral. Scler. Frontotemporal. Degener, 2019;20:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567548</ArticleId><ArticleId IdType="pubmed">30931641</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkus B, et al. Telomere shortening leads to earlier age of onset in ALS mice. Aging (Albany N. Y.) 2016;8:382&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4789589</ArticleId><ArticleId IdType="pubmed">26978042</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall T, et al. The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med. 2013;10:e1001474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692470</ArticleId><ArticleId IdType="pubmed">23824655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleiman PM, Grant SF. Mendelian randomization in the era of genomewide association studies. Clin. Chem. 2010;56:723&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pubmed">20224045</ArticleId></ArticleIdList></Reference><Reference><Citation>Paternoster L, Tilling K, Davey Smith G. Genetic epidemiology and Mendelian randomization for informing disease therapeutics: conceptual and methodological challenges. PLoS Genet. 2017;13:e1006944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5628782</ArticleId><ArticleId IdType="pubmed">28981501</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am. J. Clin. Nutr. 2016;103:965&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4807699</ArticleId><ArticleId IdType="pubmed">26961927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Codd V, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 2013;45:422&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006270</ArticleId><ArticleId IdType="pubmed">23535734</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorajoo R, et al. Loci for human leukocyte telomere length in the Singaporean Chinese population and trans-ethnic genetic studies. Nat. Commun. 2019;10:2491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554354</ArticleId><ArticleId IdType="pubmed">31171785</ArticleId></ArticleIdList></Reference><Reference><Citation>Visscher PM, et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 2017;101:5&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501872</ArticleId><ArticleId IdType="pubmed">28686856</ArticleId></ArticleIdList></Reference><Reference><Citation>Welter D, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965119</ArticleId><ArticleId IdType="pubmed">24316577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Wang T, Zheng J, Zhou X. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics. BMC Med. 2019;17:225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6892209</ArticleId><ArticleId IdType="pubmed">31796040</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, X. et al. Relationship between birth weight and chronic kidney disease: evidence from systematics review and two-sample Mendelian randomization analysis. Hum. Mol. Genet. ddaa074 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32329512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu x, et al. Alcohol drinking and amyotrophic lateral sclerosis: an instrumental variable causal inference. Ann. Neurol. 2020;88:195&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">32196748</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal association between birth weight and adult diseases: evidence from a Mendelian randomization analysis. Front. Genet. 2019;10:618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6635582</ArticleId><ArticleId IdType="pubmed">31354785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao JV, Schooling CM. Effect of linoleic acid on ischemic heart disease and its risk factors: a Mendelian randomization study. BMC Med. 2019;17:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417131</ArticleId><ArticleId IdType="pubmed">30866921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyrrell J, et al. Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank. Br. Med. J. 2016;352:i582&#x2013;i582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783516</ArticleId><ArticleId IdType="pubmed">26956984</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Burgess S, Micha&#xeb;lsson K. Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction. JAMA. 2017;318:371&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5817597</ArticleId><ArticleId IdType="pubmed">28742912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad OS, et al. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease. Nat. Commun. 2015;6:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4458864</ArticleId><ArticleId IdType="pubmed">26017687</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann. Neurol. 2014;76:120&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4137231</ArticleId><ArticleId IdType="pubmed">24931836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S, Ciura S, Rouleau GA, Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) Trends Genet. 2015;31:263&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75:860&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6043387</ArticleId><ArticleId IdType="pubmed">29630712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13:686&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat. Commun. 2017;8:611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I-2 statistic. Int. J. Epidemiol. 2016;45:1961&#x2013;1974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446088</ArticleId><ArticleId IdType="pubmed">27616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat. Methods Med. Res. 2017;26:2333&#x2013;2355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642006</ArticleId><ArticleId IdType="pubmed">26282889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 2017;46:1985&#x2013;1998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837715</ArticleId><ArticleId IdType="pubmed">29040600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavorska OO, Burgess S. Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data. Int. J. Epidemiol. 2017;46:1734&#x2013;1739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5510723</ArticleId><ArticleId IdType="pubmed">28398548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Smith GD, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 2016;40:304&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 2013;37:658&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyce AJ, et al. Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study. PLoS Med. 2017;14:e1002314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5469450</ArticleId><ArticleId IdType="pubmed">28609445</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018;50:693&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol. 2017;32:377&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, et al. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat. Commun. 2018;9:224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5768719</ArticleId><ArticleId IdType="pubmed">29335400</ArticleId></ArticleIdList></Reference><Reference><Citation>Laimer M, et al. Telomere length increase after weight loss induced by bariatric surgery: results from a 10 year prospective study. Int. J. Obes. (Lond.) 2016;40:773&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pubmed">26607038</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehkopf DH, et al. Leukocyte telomere length in relation to 17 biomarkers of cardiovascular disease risk: a cross-sectional study of US adults. PLoS Med. 2016;13:e1002188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127504</ArticleId><ArticleId IdType="pubmed">27898678</ArticleId></ArticleIdList></Reference><Reference><Citation>Revesz D, Milaneschi Y, Verhoeven JE, Penninx BWJH. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome. J. Clin. Endocrinol. Metab. 2014;99:4607&#x2013;4615.</Citation><ArticleIdList><ArticleId IdType="pubmed">25188715</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Attas OS, et al. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur. J. Endocrinol. 2010;163:601&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938925</ArticleId><ArticleId IdType="pubmed">20679357</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng Q, et al. Leukocyte telomere length, lipid parameters and gestational diabetes risk: a case-control study in a Chinese population. Sci. Rep. 2019;9:8483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6560111</ArticleId><ArticleId IdType="pubmed">31186510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Hum. Mol. Genet. 2019;28:688&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu. Rev. Psychol. 2007;58:593&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819368</ArticleId><ArticleId IdType="pubmed">16968208</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKinnon DP. Introduction to statistical mediation analysis. London: Routledge; 2008.</Citation></Reference><Reference><Citation>MacKinnon DP, Fairchild AJ. Current directions in mediation analysis. Curr. Dir. Psychol. Sci. 2009;18:16&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821103</ArticleId><ArticleId IdType="pubmed">20157637</ArticleId></ArticleIdList></Reference><Reference><Citation>Richiardi L, Bellocco R, Zugna D. Mediation analysis in epidemiology: methods, interpretation and bias. Int. J. Epidemiol. 2013;42:1511&#x2013;1519.</Citation><ArticleIdList><ArticleId IdType="pubmed">24019424</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele TJ. Mediation analysis: a Practitioner's guide. Annu. Rev. Public Health. 2016;37:17&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">26653405</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Daniel RM, Butterworth AS, Thompson SG, Consortium EP-I. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int. J. Epidemiol. 2015;44:484&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469795</ArticleId><ArticleId IdType="pubmed">25150977</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 2013;45:1274&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3838666</ArticleId><ArticleId IdType="pubmed">24097068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg JG, Donald SG. Testing identifiability and specification in instrumental variable models. Economet. Theor. 1993;9:222&#x2013;240.</Citation></Reference><Reference><Citation>The 1000 Genomes Project Consortium A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 2013;42:1497&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MS, Cui LY, Fan DS, Assoc CA. Age at onset of amyotrophic lateral sclerosis in China. Acta Neurol. Scand. 2014;129:163&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">23819875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogaki K, et al. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33(2527):e2511&#x2013;2526.</Citation><ArticleIdList><ArticleId IdType="pubmed">22727276</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez Roux AV, et al. Race/ethnicity and telomere length in the Multi-Ethnic Study of Atherosclerosis. Aging Cell. 2009;8:251&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713110</ArticleId><ArticleId IdType="pubmed">19302371</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson EM, et al. Consideration of ethnicity in guidelines and systematic reviews promoting lifestyle interventions: a thematic analysis. Eur. J. Public Health. 2014;24:508&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">23893129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5:e177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2522255</ArticleId><ArticleId IdType="pubmed">18752343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero DA, et al. Telomere length in Parkinson's disease: a meta-analysis. Exp. Gerontol. 2016;75:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786001</ArticleId><ArticleId IdType="pubmed">26772888</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, et al. Telomere length and risk of Parkinson's disease. Mov. Disord. 2008;23:302&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2387100</ArticleId><ArticleId IdType="pubmed">18044760</ArticleId></ArticleIdList></Reference><Reference><Citation>Eerola J, et al. No evidence for shorter leukocyte telomere length in Parkinson's disease patients. J. Gerontol. A Biol. Sci. Med. Sci. 2010;65:1181&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">20639300</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurks M, et al. Telomere length and Parkinson's disease in men: a nested case-control study. Eur. J. Neurol. 2014;21:93&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3943750</ArticleId><ArticleId IdType="pubmed">24010387</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan JZ, et al. A percentage analysis of the telomere length in Parkinson's disease patients. J. Gerontol. A Biol. Sci. Med. Sci. 2008;63:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">18511749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao K, et al. Exploring the causal pathway from telomere length to Alzheimer's disease: an update Mendelian randomization study. Front. Psychiatry. 2019;10:843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873744</ArticleId><ArticleId IdType="pubmed">31803085</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo YF, Yu HN. Leukocyte telomere length shortening and Alzheimer's disease etiology. J. Alzheimers Dis. 2019;69:881&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pubmed">31156167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, et al. Telomere length shortening and Alzheimer disease&#x2014;a Mendelian randomization study. JAMA Neurol. 2015;72:1202&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">26457630</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Hagg S. Telomere length shortening in Alzheimer's disease: procedures for a causal investigation using single nucleotide polymorphisms in a Mendelian randomization study. Methods Mol. Biol. 2018;1750:293&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">29512081</ArticleId></ArticleIdList></Reference><Reference><Citation>Forero DA, et al. Meta-analysis of telomere length in Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci. 2016;71:1069&#x2013;1073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945891</ArticleId><ArticleId IdType="pubmed">27091133</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig LS, Kang MS, Schupf N, Lee JH, Mayeux R. Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch. Neurol. 2012;69:1332&#x2013;1339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622729</ArticleId><ArticleId IdType="pubmed">22825311</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Ruiz C, et al. Telomere length predicts poststroke mortality, dementia, and cognitive decline. Ann. Neurol. 2006;60:174&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">16685698</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim H, et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS ONE. 2015;10:e0120758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4405269</ArticleId><ArticleId IdType="pubmed">25898129</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int. J. Epidemiol. 2011;40:755&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pubmed">21414999</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Improving bias and coverage in instrumental variable analysis with weak instruments for continuous and binary outcomes. Stat. Med. 2012;31:1582&#x2013;1600.</Citation><ArticleIdList><ArticleId IdType="pubmed">22374818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai M, et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 2018;50:390&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">29403010</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>